Global pharmaceutical companies were recently called on to pay for a $2bn (1.3bn) innovation fund for researching new antibiotics, in a report by a review team led by economist Jim O'Neill.
Mr O'Neill draws parallels between the banking crisis and the looming catastrophe of a world where antibiotics no longer work. He says that big pharma needs to act with "enlightened self-interest" because "if it gets really bad, somebody is going to come gunning for these guys just how people came gunning for finance".
But who are the real culprits?
To read the full blog sign in to vetcommunity.com